Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Buruli Ulcer | 1 | 2017 | 17 | 0.72 | Why? |
| Mycobacterium ulcerans | 1 | 2017 | 15 | 0.72 | Why? |
| Serotyping | 1 | 2018 | 154 | 0.72 | Why? |
| Marsupialia | 1 | 2017 | 27 | 0.71 | Why? |
| Serum | 1 | 2018 | 294 | 0.63 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.51 | Why? |
| B-Lymphocytes | 4 | 2021 | 4418 | 0.48 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.42 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.31 | Why? |
| Neisseria meningitidis | 2 | 2018 | 229 | 0.30 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.20 | Why? |
| Palatine Tonsil | 1 | 2021 | 127 | 0.20 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.20 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.18 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.18 | Why? |
| Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
| Soil Microbiology | 1 | 2017 | 63 | 0.17 | Why? |
| Queensland | 1 | 2017 | 188 | 0.17 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.16 | Why? |
| Meningitis, Meningococcal | 1 | 2017 | 114 | 0.15 | Why? |
| Culicidae | 1 | 2017 | 239 | 0.15 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.15 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.15 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 526 | 0.15 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
| Adjuvants, Immunologic | 2 | 2021 | 1709 | 0.14 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.13 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.12 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.10 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.09 | Why? |
| HEK293 Cells | 2 | 2020 | 8394 | 0.09 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.07 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.07 | Why? |
| Ghana | 2 | 2018 | 763 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.07 | Why? |
| Feces | 1 | 2017 | 4235 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.06 | Why? |
| Immunoglobulin D | 1 | 2021 | 24 | 0.06 | Why? |
| Genes, Immunoglobulin | 1 | 2021 | 50 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.05 | Why? |
| Immunogenetics | 1 | 2020 | 124 | 0.05 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Oligodeoxyribonucleotides | 1 | 2021 | 206 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.05 | Why? |
| Rabies Vaccines | 1 | 2021 | 106 | 0.05 | Why? |
| Squalene | 1 | 2021 | 196 | 0.05 | Why? |
| Alum Compounds | 1 | 2021 | 210 | 0.05 | Why? |
| Lymphoid Tissue | 1 | 2021 | 162 | 0.05 | Why? |
| Humans | 17 | 2021 | 930598 | 0.05 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2021 | 222 | 0.05 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2021 | 242 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Germinal Center | 1 | 2021 | 332 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Gene Transfer, Horizontal | 1 | 2017 | 64 | 0.04 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2021 | 282 | 0.04 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2021 | 1027 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Burkina Faso | 1 | 2017 | 302 | 0.04 | Why? |
| Meningitis | 1 | 2018 | 163 | 0.04 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 511 | 0.04 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Organoids | 1 | 2021 | 840 | 0.03 | Why? |
| Lymph Nodes | 1 | 2021 | 1060 | 0.03 | Why? |
| Ebolavirus | 1 | 2021 | 834 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| California | 1 | 2020 | 2047 | 0.03 | Why? |
| Viremia | 1 | 2020 | 1020 | 0.03 | Why? |
| Female | 7 | 2021 | 380317 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.03 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.01 | Why? |
Röltgen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(180)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_